Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Toxins in gastrointestinal tract" is not a single molecule or receptor but refers broadly to various toxic substances—primarily microbial proteins such as bacterial exotoxins—that can affect the gut. These include enterotoxins from bacteria like *Escherichia coli* and *Vibrio cholerae*, which cause diarrhea by disrupting ion transport and fluid balance across intestinal epithelia. Some toxins bind to specific receptors on gut cells—for example, verotoxin from EHEC binds to receptors on intestinal mucosa—leading to cell injury and disease manifestations such as hemorrhagic colitis and hemolytic–uremic syndrome[3]. The term does not refer to one defined therapeutic target but rather encompasses many different molecules with diverse structures and mechanisms of action. There are actual molecular targets within this context—such as bitter taste receptors that sense certain ingested toxins in the GI tract—but "toxins in gastrointestinal tract" itself is too broad/vague/incorrectly specified to serve as a canonical drug target name[1][3].
Various mechanisms depending on the specific toxin: - Some bacterial toxins activate guanylate cyclase to increase cGMP and fluid secretion (e.g., E. coli heat-stable enterotoxin)[3]. - Others directly damage epithelial cells or disrupt cellular signaling pathways[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toxins in gastrointestinal tract (null).